Clinical Trial: Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Prostate Cancer
Study Type: OBSERVATIONAL
Official Title: Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Brief Summary:
This study is a single-center registry study collecting clinical data regarding the treatment of PSMA-positive metastatic castration-resistant prostate cancer treated with PSMA radionuclide therapy per the treating physician's discretion.Clinical data from candidates for or who undergo the PSMA procedure at Methodist Dallas Medical Center from August 2022 to August 2027 will be collected after discharge and patients will undergo clinical follow-up per the treating physician's discretion.
Read more